Eukaryotic Initiation Factor 4E (eIF4E) sequestration mediates 4E-BP1 response to rapamycin.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
15 Mar 2019
Historique:
received: 10 09 2018
revised: 06 12 2018
accepted: 11 12 2018
pubmed: 16 12 2018
medline: 17 5 2019
entrez: 16 12 2018
Statut: ppublish

Résumé

The cap dependent translation initiation is a tightly controlled process of cooperative ternary complex formation by 4E-BP1, eIF4E and the 5' cap of eukaryotic mRNA in response to environmental cues like glucose, nutrients and growth factor levels. Based on the well-described effects of mTORC1/rapamycin complex on 4E-BP1 phosphorylation/s, it is generally accepted that rapamycin is a global inhibitor of cap-dependent translation. We have previously shown that 4E-BP1 resistance to rapamycin was overcome by the stoichiometric abundance of S6K1. Now we present evidence that the TOS-bearing amino terminal domain of S6K1 is sufficient to relieve the rapamycin resistance of 4E-BP1 as TOS deleted variants of S6K1, active or inactive with regard to S6K1 activity failed to bring about relief of 4E-BP1 resistance to rapamycin. We also show that the reciprocal inactivation of S6K1 by abundance of 4E-BP1 gets accomplished only with intact TOS motif in the protein. The data presented in this study identifies eIF4E and not Raptor as a cellular factor responsible to regulate rapamycin sensitivity of 4E-BP1 suggesting that the phosphorylation dynamics and rapamycin sensitivity of 4E-BP1 and S6K1 are regulated independently.

Identifiants

pubmed: 30552925
pii: S0141-8130(18)34816-5
doi: 10.1016/j.ijbiomac.2018.12.102
pii:
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Cell Cycle Proteins 0
EIF4EBP1 protein, human 0
Eukaryotic Initiation Factor-4E 0
Phosphoproteins 0
RNA, Messenger 0
Mechanistic Target of Rapamycin Complex 1 EC 2.7.11.1
Ribosomal Protein S6 Kinases, 70-kDa EC 2.7.11.1
ribosomal protein S6 kinase, 70kD, polypeptide 1 EC 2.7.11.1
Sirolimus W36ZG6FT64

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

651-659

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Asiya Batool (A)

Department of Biotechnology, Science Block, University of Kashmir, Srinagar, J&K 190006, India.

Sheikh Tahir Majeed (ST)

Department of Biotechnology, Science Block, University of Kashmir, Srinagar, J&K 190006, India.

Sabreena Aashaq (S)

Department of Biotechnology, Science Block, University of Kashmir, Srinagar, J&K 190006, India.

Rabiya Majeed (R)

Department of Biotechnology, Science Block, University of Kashmir, Srinagar, J&K 190006, India.

Ghazia Shah (G)

Department of Biotechnology, Science Block, University of Kashmir, Srinagar, J&K 190006, India.

Nadiem Nazir (N)

Department of Biotechnology, Science Block, University of Kashmir, Srinagar, J&K 190006, India.

Khurshid Iqbal Andrabi (KI)

Department of Biotechnology, Science Block, University of Kashmir, Srinagar, J&K 190006, India. Electronic address: andrabik@uok.edu.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH